Selective growth inhibition of cancer cells with doxorubicin-loaded CB[7]-modified iron-oxide nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective growth inhibition of cancer cells with doxorubicin-loaded CB[7]-modified iron-oxide nanoparticles

Published:2017 Issue:38 Volume:7 Page:23827-23834
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Benyettou F.¹²³,Fahs H.¹²³,Elkharrag R.¹²³,Bilbeisi R. A.¹²³,Asma B.¹²³,Rezgui R.¹²³,Motte L.⁴⁵⁶⁷⁸^ORCID,Magzoub M.¹²³,Brandel J.⁹¹⁰¹¹¹²¹³,Olsen J.-C.¹⁴¹⁵¹⁶¹⁷,Piano F.¹²³¹⁸¹⁹,Gunsalus K. C.¹²³¹⁸¹⁹,Platas-Iglesias C.²⁰²¹²²²³²⁴,Trabolsi A.¹²³^ORCID

Affiliation:

1. New York University Abu Dhabi

2. Abu Dhabi

3. United Arab Emirates

4. Université Paris 13

5. Sorbonne Paris Cité

6. Laboratoire CSPBAT

7. CNRS

8. UMR 7244

9. Equipe Reconnaissance et Procédés de Séparation Moléculaire

10. Université de Strasbourg

11. IPHC

12. 67087 Strasbourg

13. France

14. Department of Chemistry

15. University of Rochester

16. Rochester

17. USA

18. Center for Genomics and Systems Biology

19. Department of Biology

20. Departamento de Química Fundamental

21. Universidade da Coruña

22. Campus da Zapateira

23. 15008 A Coruna

24. Spain

Abstract

Cucurbit[7]uril-modified iron-oxide nanoparticles (CB[7]NPs) were loaded with doxorubicin hydrochloride (Dox) and tested as a drug delivery system.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/RA/C7RA02693E

Reference65 articles.

1. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

2. Inhibition of angiogenesis and murine tumour growth by laminarin sulphate

3. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients

4. Nanocarriers as an emerging platform for cancer therapy

5. Treating metastatic cancer with nanotechnology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin–ruthenium catalyst conjugate for bio-orthogonal uncaging of alloc group;Organic & Biomolecular Chemistry;2024

2. Sustained Delivery of Cu(II)-Based DNA Intercalators by Nanometer-Sized Cyclodextrin-Based Porous Polymers;ACS Applied Nano Materials;2023-11-10

3. Bio-evaluation of the 2-nitrochalcones as potential anti-lung cancer agents, inducers of apoptosis and inhibitors of protein kinase (VEGFR-2);Medicinal Chemistry Research;2023-08-29

4. Supramolecular Chemotherapy with Cucurbit[n]urils as Encapsulating Hosts;ACS Applied Bio Materials;2023-05-24

5. Pluronic F127 and P104 Polymeric Micelles as Efficient Nanocarriers for Loading and Release of Single and Dual Antineoplastic Drugs;Polymers;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3